Cargando…
Impaired resolution of DSS-induced colitis in mice lacking the glucocorticoid receptor in myeloid cells
Inflammatory bowel disease (IBD) is a highly prevalent intestinal disorder for which no cure exists. Currently, the standard first-line treatment of IBD consists of systemic glucocorticoid (GC) application, even though therapy can be complicated by unresponsiveness or adverse effects. In view of the...
Autores principales: | Meers, Garrit K., Bohnenberger, Hanibal, Reichardt, Holger M., Lühder, Fred, Reichardt, Sybille D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764312/ https://www.ncbi.nlm.nih.gov/pubmed/29324769 http://dx.doi.org/10.1371/journal.pone.0190846 |
Ejemplares similares
-
The Glucocorticoid Receptor in Intestinal Epithelial Cells Alleviates Colitis and Associated Colorectal Cancer in Mice
por: Muzzi, Chiara, et al.
Publicado: (2020) -
The glucocorticoid receptor in recipient cells keeps cytokine secretion in acute graft-versus-host disease at bay
por: Baake, Tina, et al.
Publicado: (2018) -
The Role of Glucocorticoids in Inflammatory Diseases
por: Reichardt, Sybille D., et al.
Publicado: (2021) -
Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids
por: Lühder, Fred, et al.
Publicado: (2017) -
Protection of Antigen-Primed Effector T Cells From Glucocorticoid-Induced Apoptosis in Cell Culture and in a Mouse Model of Multiple Sclerosis
por: Bier, Jasmina, et al.
Publicado: (2021)